CMS Entry id: 2709 | Channel: Blog landing page | Template: blog/index

Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

Blog

Fatigue and episodic memory in relapsing-remitting multiple sclerosis: A web-based CANTAB study

Clinical Scientist, Luke Allen, presented on fatigue and episodic memory in relapsing-remitting multiple sclerosis at ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis).

Read on for the key findings and full poster.

Efficient assessment of Emotional Bias using Item Response Theory and Decision Tree Computerised Ada

Director of Research & Innovation, Francesca Cormack, presented on efficient assessment of emotional bias using item response theory and decision tree computerised adaptive testing at the ISCTM Autumn Conference and the 2021 ECNP Congress.

Read on for the key findings and full poster.

Part 1: Your customer journey – Getting to know your research

In part one of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our sales team and the work they put in to ensure that we truly understand your research needs. 

Part 2: Your customer journey – Working with Cambridge Cognition

In part two of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our Operational Science team and gain some insight into the work they do to help support our academic customers.

Part 3: Your customer journey – Supporting your study

In part three of our four-part series on the journey our academic customers go through while working with Cambridge Cognition – we focus on our Customer Support and Logistics teams, diving into the work they do to help launch and support your study.

Targeting adolescent neurocognitive processes in depression to promote intervention response

Florin Tibu from the Department of Health and Human Development at the Stefan cel Mare University of Suceava recently gave us an insight into how CANTAB has impacted his research into targeting adolescent neurocognitive processes in depression to promote intervention response.

The international ENIGMA II substudy on postoperative cognitive disorders

We caught up with Dr. Guy Haller from Geneva University Hospital, to discuss the role CANTAB played in the international ENIGMA II substudy on postoperative cognitive disorders (ISEP)

Using CANTAB to understand the role of cognitive control and rumination in predicting depression amo

We recently caught up with Sanja Jandric, from the University of Osijek to discuss her research into the role of cognitive control and rumination in predicting depression among adolescents with internalising disorders.

Investigating the role of cognitive reserve in cognitive ageing

We recently caught up with Insa Feinkohl from the BioCog Consortium, to discuss the research they’ve been conducting, focusing on investigating the role of cognitive reserve in cognitive ageing.

Using CANTAB to compare the effects of augmented reality N-back training and traditional two-dimensi

We recently caught up with Dr Bo Zhang from East China Normal University to discuss her research: A Comparison of the Effects of Augmented Reality N-Back Training and Traditional Two-Dimensional N-Back Training on Working Memory

Acoustic features of voice as a measure of cognitive load during performance of serial subtraction i

Director of Research & Innovation, Francesca Cormack, presented acoustic features of voice as a measure of cognitive load during performance of serial subtraction in a remote data collection context at AAIC 2021.

Read on for the key findings and full poster.

Feasibility of Repeated Administration of Automated Verbal-Paired-Associate Memory in Older Adults

At AAIC 2021, Alex Kaula - R&D Scientist, hosted an interactive poster session on: Feasibility of Repeated Administration of Automated Verbal-Paired-Associate Memory in Older Adults

Read on for the key findings and full poster.

COVID-19 Cognitive Assessment Battery

To understand the impact of COVID-19 on cognitive function, researchers must use sensitive and reliable cognitive assessments which target appropriate domains. In this article Operational Scientist, Iona Pickett, discusses the challenges of designing a cognitive testing battery for use in those recovering from COVID-19 and describes our recommended CANTAB battery for COVID-19 studies.

Understanding the challenges of assessing cognitive function in patients recovering from COVID-19

While several initiatives have begun investigating the neuropsychological effects of COVID-19, the nature and causes of cognitive impairment found in COVID-19 survivors are not yet fully understood. In this article Operational Scientist, Iona Pickett, discusses the challenges faced by researchers assessing cognition in those recovering from COVID-19.

CANTAB Research Grant assists research into structural and functional changes in memory

We caught up with Julius Rave to talk about the impact that the primary 2021 CANTAB Research Grant prize will have on his research: Exploring structural and functional changes in memory-associated networks in patients expressing cognitive deficits after a COVID-19 infection.

Research into the cognitive impact of COVID-19 on patients with and without sleep complaints

Pim Heckman speaks to us about the impact that receiving one of the three 2021 CANTAB Research Grant prizes will have on his research into clearing COVID-19 cognitive brain fog

CANTAB used to assist with identifying patients with mild cognitive impairment and subjective cognit

Dr. Andrea McGrattan, a Research Dietitian and Lecturer in Nutrition and Dietetics, spoke to us about her PhD research at Queen’s University Belfast, using CANTAB cognitive testing within a Mediterranean Diet feasibility study, “THINK-MED”, among people with cognitive impairment.  

Adherence to a Six-Week Study of Wearable Digital Mood and Cognitive Assessments in Depression

At the 2021 SOBP Annual Meeting, our Director of Research & Innovation, Francesca Cormack hosted an interactive poster session on Adherence to a Six-Week Study of Wearable Digital Mood and Cognitive Assessments in Depression: Qualitative Insight

Read on for the key findings and full poster.

New study uses CANTAB to differentiate typical and pathological ageing

Find out more about how María Campos Magdaleno, PhD of Universidade de Santiago de Compostela is using CANTAB to investigate cognitive changes in typical and pathological ageing.

Validation of a Smartphone-based Digit Symbol Substitution Task in Participants With Major Depressio

At the virtual ISCTM - Annual Scientific Meeting, Luke Allen presented data supporting the validity of Smartphone-based DSST for assessments in patient populations such as MDD.

Read on for the key findings and the full poster: Validation and Comparability of Smartphone-based Digit Symbol Substitution Task with Written Version. 

CANTAB and CENTRE-TBI – 10 years working together

CENTRE-TBI recently concluded their 10 year study into the relationship between cognition and function in daily life after traumatic brain injury. We caught up with Prof Lindsay Wilson to hear the key findings from this worldwide study. 

Experiences of Fatigue in Chronic Disease: Effects on Mental Health

At the recent Chronic Disease & Mental Health virtual event, Iona Pickett discussed experiences of fatigue in chronic disease: effects on mental health. 

Using CANTAB to investigate specific contributions from the volume of hippocampal subregions to visu

We recently caught up with Tamara Shavitt, a psychology student who conducted research at the Faculty of Medicine, University of São Paulo to discuss how CANTAB impacted her research: investigate specific contributions from the volume of hippocampal subregions to visuospatial memory tasks.

Celebrating the women who are working to drive Cambridge Cognition forward – Part 1

To celebrate International Women's Day, we’re sharing the stories of a few of the amazing women we’re proud to say are part of the Cambridge Cognition team. In part 1 we will be speaking to Chief Operating Officer - Fiona Cree, Operational Scientist - Iona Pickett and Director of Statistical Science - Elizabeth Baker.

Celebrating the women who are working to drive Cambridge Cognition forward – Part 2

To celebrate International Women's Day, we’re sharing the stories of a few of the amazing women we’re proud to say are part of the Cambridge Cognition team. In part 2 we will be speaking to our Senior Director of Business Development, Lindsey Hagan, and our Academic Sales Manager, Emma Dominic. 

New study finds CANTAB is sensitive to very early cognitive changes in premanifest Huntington’s dise

Dr. Christelle Langley, postdoctoral Research Associate at the University of Cambridge School of Clinical Medicine shared the role that CANTAB played in her latest publication: Fronto-striatal circuits for cognitive flexibility in far from onset Huntington’s Disease: Evidence from the Young Adult Study

Cognition and COVID-19 – What we know

Nearly a year on from the first outbreak of COVID-19, we still have a lot to learn about how the virus works and affects our health. In this article Operational Scientist, Iona Pickett, explores our current understanding of the neuropsychological consequences of COVID-19, in particular the impact on cognitive function.

Lessons learned delivering virtual trials during Covid-19

Digital health expert Dr Jordan Brayanov from Takeda Pharmaceuticals shares his lessons learned delivering virtual trials during Covid-19 and predictions on what’s next for the industry.

Automated administration of Serial Subtraction in a remote data collection context: novel timing fea

New research presented at CTAD 2020 reports the successful derivation of novel measures of timing for a more nuanced assessment of performance on the Serial Subtraction task. 

2020 CANTAB Research Grant supports research into combined dexmedetomidine / ketamine nasal spray fo

The winner of one of the three 2020 CANTAB Research Grant prizes, Dr Amie Hayley, Swinburne University of Technology explains the impact CANTAB will have on her research: Combined dexmedetomidine/ketamine nasal spray for analgesia: a pilot feasibility and efficacy trial.